Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)
Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)
This study is a prospective, phase 2 extension study of participants previously enrolled in
 NTMT-01 and of participants enrolled in NTMT-02. This study is designed to evaluate long term
 safety and efficacy of the NT-501 implant in participants previously enrolled in the NTMT-01
 and NTMT-02 protocols.
Inclusion Criteria:

 -  Previously enrolled in the NTMT-01 or NTMT-02 protocol and received the NT-501 implant
 and/or underwent a Sham procedure

 -  Participant must be offered sufficient opportunity to review and to understand the
 informed consent form, agree to the form's contents, and provide written informed
 consent.

 Exclusion Criteria:

 -  There are no Exclusion Criteria